Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study
Jia‐Horng Kao(National Taiwan University Hospital), Jinzi J. Wu(Bioscience Research), Cheng‐Yuan Peng(China Medical University), Ming‐Lung Yu(National Sun Yat-sen University), Qiaoqiao Chen(University of Science and Technology of China), Chi‐Yi Chen(National Taiwan University), Huoling Tang(Bioscience Research), Ming‐Yao Chen(Taipei Medical University-Shuang Ho Hospital)
Cited by 14
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
|Annals of Internal Medicine|2016|364